Mankind Pharma's Double Play: CSR and International Growth on the Horizon

Mankind Pharma is going to introduce a wholly owned subsidiary focused on Corporate Social Responsibility (CSR) initiatives, which will further consolidate its focus on societal well-being. The company also intends to open another subsidiary in Russia, which will be a strategic push into overseas markets.

Key Highlights:

CSR Subsidiary: Mankind Pharma shall form a separate subsidiary for CSR initiatives, highlighting its commitment towards sustainable development and social well-being. This is in line with its philosophy of "Serving Life" through supplying quality products at reasonable costs.

Russian Expansion: Mankind Pharma's opening a Russian subsidiary is a reflection of its desire to have a stronger presence in the world. This is one of its steps towards its larger goal of venturing into emerging markets and broadening its international base.

Recent Developments: Mankind Pharma has been aggressively building its portfolio by making major acquisitions like Bharat Serums and Vaccines Limited (BSV) and introducing generic drugs for major drugs like empagliflozin.

This two-pronged strategy reflects Mankind Pharma's dedication to social responsibility as well as international market growth, setting it for long-term growth in the pharma sector.

Source: India CSR, The Pharma Letter, Economic Times